| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.63 | 0.02 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.35 | 0.02 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | Bosutinib | FIMM | pan-cancer | AAC | -0.24 | 0.5 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.2 | 0.001 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | -0.2 | 0.3 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.17 | 0.3 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.15 | 0.4 |